Movie Industry

'Hope' Tops the Box Office for the Seventh Consecutive Week… 'Spider-Man' Leads in Advance Ticket Sales

Director Na Hong-jin's New Film 'Hope' Cumulative Total Exceeds 2.4 Million

Choi Hee-jae
2026-07-22 09:17:31
[Edaily Starin Choi Hee-jae Reporter] Director Na Hong-jin’s new film “Hope” is dominating the box office, holding onto the No. 1 spot for its second week in theaters.
A scene from the movie “Hope” (Photo courtesy of Plus M Entertainment)

According to the Korean Film Council’s integrated computer network on the 22nd, “Hope” drew 128,902 viewers on the 21st. Its cumulative audience count stands at 2,401,626.
“Hope” is a science fiction feature film directed by Na Hong-jin—known for “The Chaser” and “The Yellow Sea”—marking his return to the genre 10 years after “The Wailing.” The film stars Hwang Jung-min, Jo In-sung, and Jung Ho-yeon, alongside Taylor Russell, Cameron Britton, Alicia Vikander, and Michael Fassbender.
In second place was Universal Pictures’ “Minions & Monsters,” which drew 18,765 viewers. Its cumulative attendance stands at 410,348. Disney’s “Moana” added 12,634 viewers that day, bringing its cumulative total to 795,819.
“The Eye,” starring Shin Min-a, and Disney·Pixar’s “Toy Story 5” took 4th and 5th place, respectively, continuing their long-running box office success.
Marvel’s flagship hero, “Spider-Man: Brand New Day,” took the top spot in advance ticket sales. “Spider-Man” attracted 311,683 advance ticket buyers.
“Hope,” which is currently on a box office roll, recorded 163,424 advance ticket sales. Director Christopher Nolan’s new film, “The Odyssey,” had 79,462 advance ticket sales.

Economy

Corporation

IT·Science

Economy

[VC's Pick] LegalTech Firm 'Legora' Expands into Korea, Secures Series E Funding

This week (October 19–23), startups in various sectors—including accommodation solutions, AI video production, and digital healthcare—secured investments from venture capital (VC) firms and accelerato…
2026-10-24 13:07:04

Corporation

“Do I Really Need a Styler?”… I Tried This One in the 20,000-won Range [Product Review]

We’re in an era of recession-driven consumption, where we want a lot but our wallets are light. Our reporter personally tests and evaluates “value-for-money alternatives” that let you keep up with tre…
2026-10-24 10:00:03

IT·Science

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
2026-10-24 06:17:02